Research Study Opportunity: CIDP Real-World Experience
A new research study is enrolling adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) to better understand how CIDP treatments work in the real world.
The study is open to adults who have been diagnosed with CIDP and are about to start treatment with efgartigimod (Vyvgart Hytrulo®). This is an observational study, which means there is no experimental medication and no changes to participants’ prescribed care. Participants will share their experiences through online questionnaires and periodic assessments conducted remotely or during home visits.
More information about the study can be found here:
Study Details | NCT07264426 | Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study | ClinicalTrials.gov
By participating, individuals can contribute valuable insights that may help advance future research and improve care for others living with CIDP.
Other Articles You May Like
Guillain-Barré Syndrome Emergency Relief Program
Making an Impact for RARE: Guillain-Barré Syndrome Emergency Relief Program The Guillain-Barré Syndrome (GBS) Emergency…
LONDC & ANF Launch “Why Behind Your Weakness” Campaign
We’re excited to announce that the Late-Onset Neuromuscular Disease Consortium (LONDC) and ANF launched the…
Speaker Series: What is the Nervous System
The nervous system plays a vital role in how your body moves, feels, and functions,…